Phase III, Randomized, Double-Blind, Placebo-Controlled,

Project: Research project

Project Details

Description

Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Study of AB103 as Compared to Placebo in Patients with Necrotizing Soft Tissue Infections (NSTI)
StatusActive
Effective start/end date7/8/157/30/20

Funding

  • ATOXBIO

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.